ClariMed Inc., a renowned player in human-centered medical device development and regulatory services, recently made waves with its strategic acquisition of We Are Human, a consultancy specializing in user-focused design and research in MedTech innovation. This move not only expands ClariMed’s geographic presence into the Southeast market but also bolsters its mission to deliver innovative, human-centered medical technologies to communities in need. With the addition of We Are Human’s expert team and Atlanta-based usability lab, led by founder Annmarie Nicolson stepping in as Principal, ClariMed is poised to enhance its offerings and capabilities significantly.
The acquisition of We Are Human represents a strategic alignment of values for ClariMed, emphasizing a deep commitment to user-centered design and research. By integrating We Are Human’s team and their ISO 13485 certified Atlanta research facility, ClariMed gains a stronger foothold in the Southeast region, enabling access to diverse study populations crucial for user research and usability testing. This move not only expands ClariMed’s service portfolio but also strengthens its position as a comprehensive medical device services partner, adept in user experience research, regulatory compliance, and design validation across the US and UK markets.
Kelley Kendle, CEO of ClariMed, highlighted that this acquisition is not merely about merging capabilities but about fortifying the company’s dedication to improving patient outcomes through safer, more intuitive medical technologies. By leveraging We Are Human’s expertise in early-stage formative research and UX research, ClariMed aims to accelerate its mission of making impactful medical technologies more accessible to those who need them the most. The shared commitment to excellence and user-centered principles between the two organizations sets a solid foundation for delivering innovative solutions to clients and end-users alike.
The integration of We Are Human into ClariMed’s network of strategic offices across the US and UK, including locations in Chadds Ford, Cambridge, San Jose, Leeds, and now Atlanta, signifies a significant expansion of the company’s geographic reach and talent pool. This broader network not only enhances ClariMed’s ability to cater to global clients but also reinforces its focus on human-centered solutions in medical device development. The combined expertise of ClariMed and We Are Human is expected to streamline processes for pharmaceutical and medical device manufacturers, facilitating faster time-to-market while prioritizing patient safety and user experience.
In essence, the acquisition of We Are Human marks a pivotal moment in the evolution of ClariMed Inc., propelling the company towards a more comprehensive and impactful approach to medical device development. By uniting forces with a like-minded partner deeply rooted in human-centered research and design, ClariMed is well-positioned to lead the way in delivering cutting-edge solutions that prioritize user needs and elevate the standard of care in healthcare.
Key Takeaways:
– The acquisition of We Are Human by ClariMed Inc. expands the latter’s reach into the Southeast market and strengthens its capabilities in user-centered design and research.
– The integration of We Are Human’s ISO 13485 certified Atlanta research facility enhances ClariMed’s presence in the Southeast region and provides access to diverse study populations for user research.
– The strategic alignment of values between ClariMed and We Are Human underscores a shared commitment to excellence and user-centered principles, driving innovation in medical device development.
– ClariMed’s acquisition of We Are Human signifies a significant step towards offering more comprehensive, human-centered solutions for pharmaceutical and medical device manufacturers, focusing on accelerating time-to-market and enhancing patient safety and user experience.
Tags: regulatory, validation
Read more on prnewswire.co.uk